Pharma M&A deal value up 31% YoY in 2025YTD amid return of mega-deals
Mergers and acquisitions (M&As) in the pharmaceutical industry already witnessed a 31% increase in total deal value from $137.1 billion …
Post
-
-
The hidden crisis in regenerative medicine
Dr Tommy Rhee, CEO of RheeGen, outlines how FDA crackdowns have revealed dangerous and unethical tissue sourcing practices: Two decades ago, …
-
Transforming medical imaging in Scotland with AI
The global shortage of radiologists is having a serious impact on diagnostics and delaying medical treatments, but AI tools for …
-
LEO Pharma applies to EMA to expand Anzupgo use to adolescents
LEO Pharma has submitted an application to the European Medicines Agency (EMA) seeking to expand the label for Anzupgo (delgocitinib) …
-
High-value oncology deals drive China’s drug licensing boom
As 2025 draws to a close, China’s meteoric rise in the innovative medicines segment has undeniably captured the attention of …
-
The hidden crisis in regenerative medicine
Dr Tommy Rhee, CEO of RheeGen, outlines how FDA crackdowns have revealed dangerous and unethical tissue sourcing practices: Two decades ago, …
-
Transforming medical imaging in Scotland with AI
The global shortage of radiologists is having a serious impact on diagnostics and delaying medical treatments, but AI tools for …
-
LEO Pharma applies to EMA to expand Anzupgo use to adolescents
LEO Pharma has submitted an application to the European Medicines Agency (EMA) seeking to expand the label for Anzupgo (delgocitinib) …
-
High-value oncology deals drive China’s drug licensing boom
As 2025 draws to a close, China’s meteoric rise in the innovative medicines segment has undeniably captured the attention of …
-
SK Capital Partners supports Swixx BioPharma’s global expansion
US-based private investment company SK Capital Partners’ affiliate has agreed to invest in Swixx BioPharma to support the latter’s next …
-
J&J gains label expansion approval for Akeega in mCSPC
Johnson & Johnson (J&J) has secured a US label expansion for its next-generation oncology combination, Akeega, in breast cancer gene …
-
First gonorrhoea antibiotics in decades herald new era of treatment
Approvals in the US for a pair of new oral antibiotics for gonorrhoea represent a significant improvement in efforts to …
-
Sanofi shares fall 6% after double setback for MS drug tolebrutinib
Sanofi’s experimental drug for multiple sclerosis (MS) has been hit with another US regulatory delay, a setback compounded by disappointing …
-
FDA approves Acadia’s Daybue Stix for Rett syndrome
The US Food and Drug Administration has approved Acadia Pharmaceuticals’ Daybue Stix (trofinetide), a dye and preservative-free powder formulation of trofinetide, …
-
Sobi buys Arthrosi to expand gout treatment pipeline
Swedish Orphan Biovitrum (Sobi) has signed an agreement for the acquisition of US-based biotechnology company Arthrosi Therapeutics, a move that …
